Preparing Future Ph.D.'s For A Changing Job Market

The market for Ph.D.'s in science and engineering is a matter of perennial concern, both to employers and to those who earn these degrees and expect to make a career in the field of their choice. Predicting supply and demand of the scientific work force, however, is a tricky business fraught with uncertainties. In 1989, widely reported statistics from the National Science Foundation caused NSF to project a shortage of Ph.D. scientists by the middle to the end of this decade. Events turned out d

Written byRichard Zare
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The market for Ph.D.'s in science and engineering is a matter of perennial concern, both to employers and to those who earn these degrees and expect to make a career in the field of their choice. Predicting supply and demand of the scientific work force, however, is a tricky business fraught with uncertainties. In 1989, widely reported statistics from the National Science Foundation caused NSF to project a shortage of Ph.D. scientists by the middle to the end of this decade. Events turned out differently, and it is instructive to understand what happened.

From what I can discern, NSF projected a drop in the number of bachelor's degrees in the natural sciences and in engineering based on a demographic decline in the number of college-age Americans. NSF then put forward a pipeline model in which bigger pipes feed smaller pipes in a progression from K-12 to undergraduate to graduate degrees. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies